The Alliance’s blog offers a personal, inside look at our activities and perspectives on a range of timely issues. We encourage your feedback.

Big Boost for Alzheimer's

Author: Sue Peschin

Date: February 9th, 2012

This week’s press event announcing an immediate $50 million infusion of NIH funding to Alzheimer’s research—along with commitments to include an additional $80 million in research dollars and $26 million in services and supports in the President’s FY 2013 budget—was monumental on a number of fronts.

Why Isn't Alzheimer's Research Keeping Up with the Disease?

Author: Dan Perry

Date: October 26th, 2011

Alzheimer’s is the only top 10 killer disease in the U.S. that cannot be prevented, cured or even treated effectively over time. One big barrier: there are not enough volunteers for experimental drug trials for Alzheimer’s disease.

Gap between Beliefs and Actions in Early Detection of Alzheimer's

Author: Lindsay Clarke

Date: November 18th, 2008

While most people in a recent survey said they would encourage a loved one to seek early diagnosis if they suspected Alzheimer’s disease, when faced with the reality, only a small number sought out early diagnosis.

What Can You Do to Stop Alzheimer's

Author: Guest Contributor

Date: May 22nd, 2008

Last week, former Supreme Court Justice Sandra Day O’Connor shared personal testimony before the Senate Special Committee on Aging about the burden of Alzheimer’s disease. O’Connor stepped down from the court in 2006 to care for her husband, who has the disease. As many people know, Alzheimer’s is an overwhelming disease-both on a personal level for families and for society. 

Responding to the Aging of the Population

Author: Cynthia Bens

Date: January 9th, 2012

A group of aging and Alzheimer’s advocates will be meeting this week with the senior leadership of the National Institutes of Health (NIH) to call for an increase in funding for the National Institute on Aging (NIA). In advance of this meeting, the group has orchestrated a sign-on letter to demonstrate widespread support for $1.4 billion, an increase of $300 million, in the FY 2013 NIH Budget to support the NIA. A similar letter was generated last year and garnered more than 400 signatures.

Expert Dr. Rudolph E. Tanzi Optimistic about the Future of Alzheimer's Research

Author: Noel Lloyd

Date: October 27th, 2015

At last month's annual dinner, the Alliance gave eminent Harvard researcher Rudolph E. Tanzi. Ph.D., the Silver Innovator Award for spearheading his research lab’s “Alzheimer’s-in-a-dish model,” a revolutionary 3-D discovery that gives new hope for the development of therapies to treat and cure the condition. 

Expert Jason Karlawish on Alzheimer's Disease, Bioethics, and the Future of Medicine

Author: Noel Lloyd

Date: September 18th, 2015

This is the first in our occasional series of stories about experts who research aging and the chronic diseases of later life.  For our debut entry, we introduce you to Jason Karlawish, M.D.

ACT-AD Coalition Holds Eighth Annual Meeting

Author: Noel Lloyd

Date: September 18th, 2015

On September 16 the ACT-AD (Accelerate Cure/Treatments for Alzheimer's Disease) Coalition hosted its Eighth Annual FDA/Alzheimer’s Disease Allies Meeting in North Bethesda, Md.

Friends of the NIA Comments on Senate NIH Funding Bill

Author: Noel Lloyd

Date: June 26th, 2015

The Friends of the NIA has made the following statement on the Senate NIH Funding bill.

Three Things to Know about Alzheimer's Disease

Author: Noel Lloyd

Date: June 24th, 2015

We want to share three facts you should know about Alzheimer's disease; facts that are both sobering and encouraging.

NIA Seeks Volunteers for Alzheimer’s Disease Clinical Trials

Author: Noel Lloyd

Date: May 5th, 2015

Right now across the U.S. there are more than 150 Alzheimer’s disease and related clinical trials being conducted.

NIH Puts Focus on Alzheimer's

Author: Noel Lloyd

Date: April 16th, 2015

Over the last couple of weeks, the National Institutes of Health has shared several updates about its work surrounding Alzheimer's disease and dementia. 

Alliance Submits Suggestions for NIA's Aging Well in the 21st Century

Author: Noel Lloyd

Date: December 15th, 2014

The National Institute on Aging recently put out a call for comments and ideas for a draft of its strategic directions document, Aging Well in the 21st Century.

World Alzheimer’s Month: Improving Prevention and Treatment

Author: Bryan Luce and Jean Slutsky

Date: September 23rd, 2014

This is a guest post from the Patient-Centered Outcomes Research Institute on World Alzheimer's Month. 

Update: Talaya Waller Birthday Update

Author: Noel Lloyd

Date: July 1st, 2014

We want to thank Talaya Waller for her commitment to Alzheimer's research and for including us in her special tribute to her grandmother.

A Birthday Party to Celebrate Aging…and the Research Behind It

Author: Noel Lloyd

Date: June 4th, 2014

Talaya Waller turns 29 this month, and she’s throwing a big party in Washington, D.C., on June 21.

Alliance Hosts Alzheimer's Film Screening at French Embassy

Author: Noel Lloyd

Date: April 28th, 2014

On Thursday evening, April 24, the French Embassy in Washington, D.C., played host to the big screen debut of A Quick Look at Alzheimer's.

Are we there yet?

Author: Cynthia Bens

Date: January 6th, 2012

Many of you may still have this phrase ringing in your ears if you traveled with children for any length of time this past holiday season. Representatives from the ACT-AD Coalition, chaired by the Alliance for Aging Research, heard these same words almost two years ago, not uttered from the mouths of babes, but rather by prominent officials at the Food and Drug Administration (FDA) in a conversation regarding evidence to support the use of biomarkers for Alzheimer’s disease in clinical trials for “disease-modifying” therapies.

Breakthroughs in Understanding Diseases of Aging Earn Top Honors

Author: Guest Contributor

Date: December 14th, 2011

This November, the Cleveland Clinic Foundation (CCF) released its “Top Ten Medical Innovations” list for 2011, and five of those top ten show great promise for diseases of aging,

"Rescuing Cognition": CA vs. Alzheimer's Disease ~ By Don Reed

Author: Dan Perry

Date: February 2nd, 2011

This is one of the best articles on Alzheimer's I’ve seen to date. It is written by Don C. Reed, a stem cell activist in California, on the promise of current research, and on embryonic stem cells; bringing attention to a subject that is often forgotten and underfunded.


The Alzheimer's Epidemic Marches On

Author: Guest Contributor

Date: March 26th, 2009

Alzheimer’s disease has taken an unfortunate step in front of the national news spotlight as of late. The last two evenings, I have seen features on the evening news highlighting the devastating effects of the disease both as a public health epidemic and as a personal, family struggle.

Early Detection of Alzheimer's a High Priority for Consumers

Author: Lindsay Clarke

Date: October 29th, 2008

Voters for the American Express Members Project recently chose the Alzheimer’s Disease: Early Detection Matters campaign as the project they would most like to see funded. Close to 90,000 card members cast a vote—choosing from more than 1,000 potential projects. In the end, the winner was a campaign that will educate people about the importance of early diagnosis of Alzheimer’s—receiving $1.5 million in funding.

Easing the Burden for Alzheimer's Caregivers

Author: Guest Contributor

Date: May 9th, 2008

About 10 million of the almost 45 million caregivers in the United States care for individuals with Alzheimer’s disease. Most of these caregivers are not prepared for their new role, which takes a toll on their mental and physical health. Furthermore, Alzheimer’s disease is often called a “family disease,” because the daily stress of watching a loved one slowly decline affects the whole family.

Why Get a Memory Screening?

Author: Noel Lloyd

Date: November 4th, 2015

Some advice on why you might want to consider getting a memory screening.

Participate in an Alzheimer's Disease Clinical Trial

Author: Noel Lloyd

Date: November 12th, 2015

Participating in Alzheimer's disease clinical trials is a valuable way you and your loved ones can personally impact this disease.

Webinar: Targets for the Next Generation of Alzheimer’s Disease Treatment

Author: Noel Lloyd

Date: May 11th, 2015

On April 27 the Alliance's ACT-AD Coalition held a webinar on the future of research, therapeutic development, and treatment of Alzheimer’s disease.

Dr. Rudolph Tanzi to Be Honored as Alliance's 2015 Silver Innovator Award Winner

Author: Noel Lloyd

Date: April 7th, 2015

Rudolph Tanzi, Ph.D., has been announced as the Alliance's 2015 Silver Innovator Award winner.

Recommendations for Advancing Alzheimer’s Interventions

Author: Cynthia Bens

Date: December 18th, 2012

This week the Alliance for Aging Research and the U.S. Administration on Aging (AoA) released a new white paper titled Translating Innovation to Impact: Evidence-based interventions to support people with Alzheimer's disease and their caregivers at home and in their communities.

Study Looks at Alzheimer's Potential Impact on China

Author: Noel Lloyd

Date: January 21st, 2016

A new study discusses the potential long-term impacts China could face from Alzheimer's disease.

Alzheimer's Disease and Personalized Medicine Webinar/February 29

Author: Noel Lloyd

Date: February 8th, 2016

On February 29, the ACT-AD coalition holds a webinar about Alzheimer's disease and personalized medicine. 

Bill for Alzheimer’s Disease Postal Stamp Introduced in U.S. House of Representatives

Author: Noel Lloyd

Date: March 2nd, 2016

A bill has been introduced in the U.S. House of Representatives for a Alzheimer's disease research postal stamp.

We Bring People and Organizations Together to Advance Science

Author: Noel Lloyd

Date: May 13th, 2016

A major way the Alliance advances science is through building coalitions of diverse organizations and individuals to bring visibility and support to health research, with the ultimate goal of improving the healthy length and quality of life for everyone. Learn more. 

HROTW: Alzheimer's: The Race to the Cure

Author: Noel Lloyd

Date: November 6th, 2015

Our Health Resource of the Week is a short video that focuses on how researchers are looking for ways to stop Alzheimer's disease.

HROTW: Video Intro to Alzheimer's

Author: Noel Lloyd

Date: June 25th, 2015

Since June is Alzheimer's & Brain Awareness Month, we think this Health Resource of the Week would be appropriate.

A Look Back at Alliance Dinner Speeches Past

Author: Noel Lloyd

Date: May 5th, 2016

Welcome to the next edition of the Artifacts Collection. For this edition, we take a step back into our digital archives to show you the speeches of two of our previous Annual Dinner honorees: Dr. Rudy Tanzi and Jeremy Bloom.

Alliance's Bens Speaks at Capitol Hill Briefing on Precision Medicine

Author: Noel lloyd

Date: June 24th, 2016

On Wednesday, the Alliance’s Vice President of Public Policy Cynthia Bens spoke at a Congressional Life Sciences Caucus briefing about precision medicine on Capitol Hill.

A Look Back at Alliance Dinner Speeches Past, Part II

Author: Noel Lloyd

Date: May 25th, 2016

Welcome to the next edition of the Artifacts Collection. For this edition, we take another step back into our digital archives to show you the speeches of two more of our previous Annual Dinner honorees: Scott Simon and Mitchell E. Daniels Jr.

ACT-AD Holds Webinar on Clinical Meaningfulness in Alzheimer’s Disease

Author: Noel Lloyd

Date: July 25th, 2016

On July 19, 2016, the ACT-AD Coalition presented an one-hour webinar on clinical meaningfulness in Alzheimer’s disease.

Congress and the Omnibus Miracle

Author: Susan Peschin, MHS

Date: December 17th, 2015

Congress gave Americans a holiday miracle this week and reached a deal on a $1.1 trillion omnibus spending bill for FY 2016, increasing funding for NIH, NIA, and FDA.

We Are Family: Alzheimer's Caregivers and the Role of Community

Author: Noel Lloyd

Date: June 16th, 2016

Jeanie Harris and Sharon R. Melancon had their lives changed when their 91-year-old mom, Peggy, was diagnosed with Alzheimer's disease. Here is their story of how they endured the heartache of losing their mom, found the support in the love of family, and started a community to connect their fellow Alzheimer's caregivers.

ACT-AD Will Host Ninth Annual Meeting

Author: Breanna Bishop

Date: October 31st, 2016

The ACT-AD Coalition will host its Ninth Annual FDA/Alzheimer's Disease Allies Meeting on November 16, 2016. 

ACT-AD Coalition Holds Ninth Annual Meeting

Author: Breanna Bishop

Date: November 22nd, 2016

On November 16, the ACT-AD (Accelerate Cure/Treatments for Alzheimer’s Disease) Coalition hosted its Ninth Annual FDA/Alzheimer’s Disease Allies Meeting in North Bethesda, Md., to discuss the current state of Alzheimer’s disease treatment development.

Webinar on Symptomatic Relief for Alzheimer's/March 15

Author: Breanna Bishop

Date: March 6th, 2017

On Wednesday, March 15, at 12 p.m. EST, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition will hold a one-hour webinar on symptomatic relief for Alzheimer’s disease, featuring expert presentations.

ACT-AD Coalition's Webinar on Symptomatic Relief for Alzheimer's Available Now

Author: Breanna Bishop

Date: March 24th, 2017

On March 15, the Accelerate Cure/Treatments for Alzheimer's Disease (ACT-AD) Coalition hosted a webinar on symptomatic relief for Alzheimer's disease. An archived video of the webinar is now available. 

Alzheimer's Disease Begins Before Symptoms Start, Researchers Say

Author: Breanna Bishop

Date: June 19th, 2017

Researchers at the Keck School of Medicine of the University of Southern California may have discovered Alzheimer's disease in its earliest stage. Their findings provide greater insight into the disease and could offer new ways to treat the devastating disease.

Alzheimer’s Association International Conference Recap

Author: Ryne Carney

Date: August 10th, 2017

Last month, the Alzheimer’s Association International Conference was held in London, England. While we are still years away from discovering a cure, the conference highlights the steady efforts of researchers and scientists to better understand the devastating disease.

An Update on the Clinical Trials for Alzheimer’s Disease Conference

Author: Noel Lloyd

Date: November 7th, 2017

Last week was the Clinical Trials for Alzheimer’s Disease (CTAD) conference in Boston. The Alliance's Missy Jenkins and Ryne Carney were in attendance, as were those from various other organizations. We are pleased to present a post from Eric Sokol, vice president, Public Policy, the Alzheimer’s Foundation, about some of the highlights from the conference.

A Recap of the Clinical Trials for Alzheimer’s Disease Conference

Author: Phyllis Greenberger

Date: December 1st, 2017

Last month, the Clinical Trials for Alzheimer's Disease (CTAD) conference was held in Boston. Phyllis Greenberger, Senior Vice President of Science & Health Policy, HealthyWomen, shares her experiences at the conference.

Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It